Literature DB >> 10327418

Expression and regulation of complement C1q by human THP-1-derived macrophages.

D G Walker1.   

Abstract

The regulation of C1q expression was examined in the human monocytic cell line THP-1. Since these cells can be differentiated into cells with macrophage properties and induced to express C1q, they were used as models for mature human monocyte/macrophages and indirectly microglia. Interferon-gamma (IFN-gamma) and the anti-inflammatory steroid agents dexamethasone and prednisone were powerful stimulators of C1q production, alone or in combination. Interleukin-6 (IL-6) and lipopolysaccharide (LPS) also had significant stimulatory activity. Phorbol myristate acetate, a protein kinase C activator, reduced C1q expression. Four additional classes of pharmacological agents were tested for their effect on C1q secretion. Tacrine, but not indomethacin, cimetidine, or propentofylline, showed activity in inhibiting C1q secretion by IFN-gamma treated THP-1-derived macrophages.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10327418     DOI: 10.1007/bf02815080

Source DB:  PubMed          Journal:  Mol Chem Neuropathol        ISSN: 1044-7393


  8 in total

1.  The complement C1qA enhances retinoic acid-inducible gene-I-mediated immune signalling.

Authors:  Yetao Wang; Xiaomei Tong; Junjie Zhang; Xin Ye
Journal:  Immunology       Date:  2012-05       Impact factor: 7.397

Review 2.  Inflammation and Alzheimer's disease.

Authors:  H Akiyama; S Barger; S Barnum; B Bradt; J Bauer; G M Cole; N R Cooper; P Eikelenboom; M Emmerling; B L Fiebich; C E Finch; S Frautschy; W S Griffin; H Hampel; M Hull; G Landreth; L Lue; R Mrak; I R Mackenzie; P L McGeer; M K O'Banion; J Pachter; G Pasinetti; C Plata-Salaman; J Rogers; R Rydel; Y Shen; W Streit; R Strohmeyer; I Tooyoma; F L Van Muiswinkel; R Veerhuis; D Walker; S Webster; B Wegrzyniak; G Wenk; T Wyss-Coray
Journal:  Neurobiol Aging       Date:  2000 May-Jun       Impact factor: 4.673

Review 3.  Early life stress perturbs the function of microglia in the developing rodent brain: New insights and future challenges.

Authors:  Frances K Johnson; Arie Kaffman
Journal:  Brain Behav Immun       Date:  2017-06-15       Impact factor: 7.217

4.  Reduced expression of C1q-mRNA in monocytes from patients with systemic lupus erythematosus.

Authors:  F Moosig; F Damm; A Knorr-Spahr; M Ritgen; R A Zeuner; M Kneba; M Ernst; J O Schröder
Journal:  Clin Exp Immunol       Date:  2006-12       Impact factor: 4.330

5.  Transcriptional control of complement activation in an exercise model of chronic fatigue syndrome.

Authors:  Bristol Sorensen; James F Jones; Suzanne D Vernon; Mangalathu S Rajeevan
Journal:  Mol Med       Date:  2008-11-10       Impact factor: 6.354

6.  Human postmortem brain-derived cerebrovascular smooth muscle cells express all genes of the classical complement pathway: a potential mechanism for vascular damage in cerebral amyloid angiopathy and Alzheimer's disease.

Authors:  Douglas G Walker; Jessica E Dalsing-Hernandez; Lih-Fen Lue
Journal:  Microvasc Res       Date:  2007-11-01       Impact factor: 3.514

7.  Complement C1q is hydroxylated by collagen prolyl 4 hydroxylase and is sensitive to off-target inhibition by prolyl hydroxylase domain inhibitors that stabilize hypoxia-inducible factor.

Authors:  Serafim Kiriakidis; Simon S Hoer; Natalie Burrows; Gloria Biddlecome; Moddasar N Khan; Cyrille C Thinnes; Christopher J Schofield; Norma Rogers; Marina Botto; Ewa Paleolog; Patrick H Maxwell
Journal:  Kidney Int       Date:  2017-05-12       Impact factor: 10.612

8.  MafB is a critical regulator of complement component C1q.

Authors:  Mai Thi Nhu Tran; Michito Hamada; Hyojung Jeon; Risako Shiraishi; Keigo Asano; Motochika Hattori; Megumi Nakamura; Yuki Imamura; Yuki Tsunakawa; Risa Fujii; Toshiaki Usui; Kaushalya Kulathunga; Christina-Sylvia Andrea; Ryusuke Koshida; Risa Kamei; Yurina Matsunaga; Makoto Kobayashi; Hisashi Oishi; Takashi Kudo; Satoru Takahashi
Journal:  Nat Commun       Date:  2017-11-22       Impact factor: 14.919

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.